Risperidone in non-epileptic attack disorder and chromosome 15q deletion syndrome

Abstract

Chromosome 15q11.2 microdeletion is an emerging syndrome identified in individuals with Prader-Willi syndrome and Angelman syndrome but also found in isolation. Here, the authors present a case of a 19-year-old woman with chromosome 15q11.2 microdeletion and her successful treatment with risperidone, a tailored positive behaviour support plan and with staff training around non-epileptic attack disorder.